2026 Q2 Portfolio Activity
In 2026 Q2, Defilade Capital Management, L.P. maintained a portfolio of 51 distinct positions. The most significant new addition was VEEVA SYS INC, now representing 5.62% of the total fund value. They heavily accumulated shares in ELI LILLY & CO, increasing the position by 88.9%. Conversely, Defilade Capital Management, L.P. completely exited their position in SCHEIN HENRY INC.
Position History
hover any row below to update
Loading…
Total Positions
51
Quarter
2026 Q2
Top Holding
LLY (6.3%)
Top 10 Concentration
46.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 51
Defilade Capital Management, L.P. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LLY
ELI LILLY & CO
|
Healthcare | 6.28% | 2.67% |
#1
16
Prev: #17
|
7.5 |
—
|
18,390 | 88.9% |
P
S
|
39,086 | $46,880,921 |
$1116.35
+9.8%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PFE
PFIZER INC
|
Healthcare | 5.71% | 2.72% |
#2
14
Prev: #16
|
6.3 |
—
|
307,614 | 21.0% |
P
S
|
1,771,743 | $42,663,571 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VEEV
VEEVA SYS INC
|
Healthcare | 5.62% | — |
#3
Prev: #—
|
6.7 |
—
|
236,709 | — |
NEW
|
236,709 | $42,008,746 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 5.22% | — |
#4
Prev: #—
|
6.1 |
—
|
682,005 | — |
NEW
|
682,005 | $39,024,326 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 4.74% | 5.77% |
#5
1
Prev: #4
|
4.4 |
—
|
57,534 | 15.3% |
P
S
|
433,699 | $35,376,827 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BAX
BAXTER INTL INC
|
Healthcare | 4.17% | — |
#6
Prev: #—
|
5.2 |
—
|
1,459,380 | — |
NEW
|
1,459,380 | $31,113,982 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 4.02% | 4.48% |
#7
Prev: #7
|
4.1 |
—
|
86,929 | 44.6% |
P
S
|
281,838 | $30,049,568 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 3.66% | 7.35% |
#8
7
Prev: #1
|
1.5 |
—
|
-261,735 | -45.2% |
P
S
|
317,426 | $27,327,204 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PODD
INSULET CORP
|
Healthcare | 3.61% | — |
#9
Prev: #—
|
4.9 |
—
|
176,932 | — |
NEW
|
176,932 | $26,937,897 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 3.49% | — |
#10
Prev: #—
|
4.9 |
—
|
51,934 | — |
NEW
|
51,934 | $26,037,630 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 3.47% | — |
#11
Prev: #—
|
4.9 |
—
|
285,778 | — |
NEW
|
285,778 | $25,931,496 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 3.39% | — |
#12
Prev: #—
|
4.9 |
—
|
94,843 | — |
NEW
|
94,843 | $25,296,525 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
SOLV
SOLVENTUM CORP
|
Healthcare | 3.27% | — |
#13
Prev: #—
|
4.8 |
—
|
316,454 | — |
NEW
|
316,454 | $24,414,426 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 3.18% | — |
#14
Prev: #—
|
4.8 |
—
|
303,301 | — |
NEW
|
303,301 | $23,727,237 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELAN
ELANCO ANIMAL H...
|
Healthcare | 2.85% | 3.13% |
#15
Prev: #15
|
1.6 |
—
|
-67,041 | -7.2% |
P
S
|
864,080 | $21,265,009 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 2.72% | — |
#16
Prev: #—
|
4.6 |
—
|
546,848 | — |
NEW
|
546,848 | $20,293,529 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVST
ENVISTA HOLDING...
|
Healthcare | 2.56% | — |
#17
Prev: #—
|
4.5 |
—
|
726,108 | — |
NEW
|
726,108 | $19,132,946 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.08% | 4.31% |
#18
9
Prev: #9
|
0.8 |
—
|
-233,145 | -73.8% |
P
S
|
82,827 | $15,511,841 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ICUI
ICU MED INC
|
Healthcare | 2.07% | 4.61% |
#19
13
Prev: #6
|
0.8 |
—
|
-148,591 | -58.4% |
P
S
|
105,700 | $15,495,620 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.04% | 1.91% |
#20
3
Prev: #23
|
2.8 |
—
|
40,851 | 11.6% |
P
S
|
393,441 | $15,226,167 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 1.97% | 2.66% |
#21
3
Prev: #18
|
0.8 |
—
|
-116,739 | -46.8% |
P
S
|
132,662 | $14,717,522 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.96% | 1.77% |
#22
3
Prev: #25
|
1.3 |
—
|
2,641 | 0.2% |
P
S
|
1,490,286 | $14,634,609 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 1.86% | 1.54% |
#23
5
Prev: #28
|
1.2 |
—
|
-38,789 | -1.1% |
P
S
|
3,525,338 | $13,889,832 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 1.61% | — |
#24
Prev: #—
|
4.1 |
—
|
376,870 | — |
NEW
|
376,870 | $12,037,228 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.55% | 3.15% |
#25
11
Prev: #14
|
0.6 |
—
|
-579,778 | -38.5% |
P
S
|
924,758 | $11,568,723 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.52% | 1.50% |
#26
3
Prev: #29
|
3.1 |
—
|
204,762 | 24.3% |
P
S
|
1,047,690 | $11,346,483 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 1.50% | — |
#27
Prev: #—
|
4.1 |
—
|
3,670,135 | — |
NEW
|
3,670,135 | $11,193,912 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMED
GLOBUS MED INC
|
Healthcare | 1.48% | 4.29% |
#28
18
Prev: #10
|
0.6 |
—
|
-214,713 | -60.6% |
P
S
|
139,637 | $11,032,719 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENOV
ENOVIS CORPORAT...
|
Healthcare | 1.47% | — |
#29
Prev: #—
|
4.1 |
—
|
531,945 | — |
NEW
|
531,945 | $11,011,262 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 1.41% | 2.19% |
#30
9
Prev: #21
|
2.6 |
—
|
114,556 | 16.9% |
P
S
|
793,145 | $10,540,897 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TFX
TELEFLEX INCORP...
|
Healthcare | 1.36% | — |
#31
Prev: #—
|
4.0 |
—
|
80,118 | — |
NEW
|
80,118 | $10,155,758 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 1.35% | 3.67% |
#32
20
Prev: #12
|
0.5 |
—
|
-968,103 | -71.2% |
P
S
|
391,866 | $10,078,794 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 1.24% | — |
#33
Prev: #—
|
4.0 |
—
|
66,519 | — |
NEW
|
66,519 | $9,296,695 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STAA
STAAR SURGICAL ...
|
Healthcare | 1.24% | — |
#34
Prev: #—
|
4.0 |
—
|
322,126 | — |
NEW
|
322,126 | $9,241,795 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PACS
PACS GROUP INC
|
Healthcare | 1.23% | 3.60% |
#35
22
Prev: #13
|
0.5 |
—
|
-388,505 | -64.3% |
P
S
|
215,675 | $9,196,382 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 1.20% | — |
#36
Prev: #—
|
4.0 |
—
|
239,440 | — |
NEW
|
239,440 | $8,959,845 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 1.18% | — |
#37
Prev: #—
|
4.0 |
—
|
107,373 | — |
NEW
|
107,373 | $8,829,282 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BDTX
BLACK DIAMOND T...
|
Healthcare | 0.41% | — |
#38
Prev: #—
|
3.7 |
—
|
1,674,999 | — |
NEW
|
1,674,999 | $3,098,748 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MREO
MEREO BIOPHARMA...
|
Healthcare | 0.32% | 0.35% |
#39
8
Prev: #31
|
1.1 |
—
|
no change | no change |
P
S
|
7,558,756 | $2,401,417 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 0.38% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-315,944 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.00% | 1.62% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-67,332 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 1.67% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-51,895 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.00% | 1.87% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-129,950 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 0.00% | 2.05% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-761,905 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.00% | 2.48% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-96,289 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ITGR
INTEGER HLDGS C...
|
Healthcare | 0.00% | 2.63% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-213,027 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.00% | 3.88% |
Sold All 😨
(Was: #11) |
0.0 |
—
|
-209,932 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.00% | 4.38% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-67,681 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.00% | 4.75% |
Sold All 😨
(Was: #5) |
0.0 |
—
|
-538,762 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 0.00% | 6.16% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-279,210 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 51 holdings